ArticleOncology letters2018

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer.

Qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.